Goldman Sachs Group Inc Biotechnology

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$141 Million
269K
Q2 2025
Reduced 4.88%
INSM
Insmed Inc
PUT
$24.2 Million
240K
Q2 2025
Added 29.11%
NVO
Novo Nordisk A S
PUT
$21.6 Million
314K
Q2 2025
Reduced 7.88%
UTHR
United Therapeutics Corp
CALL
$20.1 Million
70K
Q2 2025
Added 94.09%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$14.2 Million
27.1K
Q2 2025
Reduced 4.88%
VRTX
Vertex Pharmaceuticals Inc
PUT
$13.9 Million
31.2K
Q2 2025
Added 11.37%
INSM
Insmed Inc
CALL
$10.1 Million
100K
Q2 2025
Added 29.11%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$9.78 Million
30K
Q2 2025
Added 28.8%
SWTX
Spring Works Therapeutics, Inc.
CALL
$9.4 Million
200K
Q2 2025
Added 263.44%
VRTX
Vertex Pharmaceuticals Inc
CALL
$7.88 Million
17.7K
Q2 2025
Added 11.37%
BNTX
Bio N Tech Se
CALL
$5.55 Million
52.1K
Q2 2025
Reduced 31.86%
BBIO
Bridge Bio Pharma, Inc.
PUT
$5.4 Million
125K
Q2 2025
Added 17.9%
NVO
Novo Nordisk A S
CALL
$4.14 Million
60K
Q2 2025
Reduced 7.88%
SRPT
Sarepta Therapeutics, Inc.
CALL
$3.72 Million
217K
Q2 2025
Added 106.66%
LEGN
Legend Biotech Corp
PUT
$3.53 Million
99.4K
Q2 2025
Reduced 1.25%
ARGX
Argenx Se
CALL
$2.76 Million
5K
Q2 2025
Reduced 15.77%
VKTX
Viking Therapeutics, Inc.
CALL
$2.39 Million
90K
Q2 2025
Added 10.09%
BNTX
Bio N Tech Se
PUT
$2.24 Million
21K
Q2 2025
Reduced 31.86%
BBIO
Bridge Bio Pharma, Inc.
CALL
$1.94 Million
45K
Q2 2025
Added 17.9%
ACAD
Acadia Pharmaceuticals Inc
CALL
$1.94 Million
89.8K
Q2 2025
Reduced 32.6%
ACAD
Acadia Pharmaceuticals Inc
PUT
$1.94 Million
89.8K
Q2 2025
Reduced 32.6%
ASND
Ascendis Pharma A/S
CALL
$1.8 Million
10.4K
Q2 2025
Reduced 8.08%
AKRO
Akero Therapeutics, Inc.
CALL
$1.49 Million
27.9K
Q2 2025
Added 56.79%
INCY
Incyte Corp
PUT
$1.43 Million
21K
Q2 2025
Added 26.06%
INCY
Incyte Corp
CALL
$1.43 Million
21K
Q2 2025
Added 26.06%
VERV
Verve Therapeutics, Inc.
PUT
$1.43 Million
127K
Q2 2025
Added 4.92%
CYTK
Cytokinetics Inc
CALL
$1.3 Million
39.2K
Q2 2025
Reduced 6.53%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$1.28 Million
81.3K
Q2 2025
Added 21.45%
ADPT
Adaptive Biotechnologies Corp
CALL
$1.25 Million
107K
Q2 2025
Reduced 3.89%
NVAX
Novavax Inc
CALL
$1.18 Million
187K
Q2 2025
Reduced 1.54%
NVAX
Novavax Inc
PUT
$1.18 Million
187K
Q2 2025
Reduced 1.54%
CRSP
Crispr Therapeutics Ag
CALL
$1.13 Million
23.3K
Q2 2025
Added 49.73%
LEGN
Legend Biotech Corp
CALL
$1.06 Million
30K
Q2 2025
Reduced 1.25%
SRPT
Sarepta Therapeutics, Inc.
PUT
$976,000
57.1K
Q2 2025
Added 106.66%
QURE
Uni Qure N.V.
CALL
$836,000
60K
Q2 2025
Added 37.29%
SMMT
Summit Therapeutics Inc.
CALL
$832,000
39.1K
Q2 2025
Reduced 47.03%
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$723,000
19.9K
Q2 2025
Reduced 11.3%
PCVX
Vaxcyte, Inc.
CALL
$682,000
21K
Q2 2025
Reduced 18.53%
CNTA
Centessa Pharmaceuticals PLC
PUT
$486,000
37K
Q2 2025
Added 39.21%
MRNA
Moderna, Inc.
CALL
$402,000
14.6K
Q2 2025
Added 5.85%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$363,000
21K
Q2 2025
Reduced 29.8%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$363,000
21K
Q2 2025
Reduced 29.8%
AXSM
Axsome Therapeutics, Inc.
CALL
$229,000
2.2K
Q2 2025
Reduced 24.37%
NTLA
Intellia Therapeutics, Inc.
CALL
$151,000
16.2K
Q2 2025
Reduced 15.16%
NTLA
Intellia Therapeutics, Inc.
PUT
$151,000
16.2K
Q2 2025
Reduced 15.16%
Filter Shares Options
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email